FLGT - Fulgent Genetics, Inc.
Fulgent Genetics, Inc. , together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests.
As of May 15, 2026: spot at $15.74, ATM IV 44.9%, max pain $17.50, net GEX $24.5K.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Market Cap
- $453.3M
- Beta
- 0.88
- 52-Week Range
- 13.46-31.04
- CEO
- Ming Hsieh
- Employees
- 1,313
- IPO Date
- Sep 29, 2016
- Exchange
- NASDAQ
What FLGT Looks Like to Options Traders Today
IV rank of 10.2% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($24.5K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.046) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The FLGT overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked FLGT overview questions
- What is FLGT?
- FLGT is the ticker symbol for Fulgent Genetics, Inc., a listed security. Fulgent Genetics, Inc. , together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. Listed on NASDAQ. FLGT is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the FLGT options snapshot look like today?
- As of May 15, 2026, the FLGT options snapshot shows spot at $15.74, ATM IV 44.9%, IV rank 10.2%, max pain $17.50, net GEX $24.5K, expected move 12.87%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are FLGT's key statistics?
- Fulgent Genetics, Inc. (FLGT) carries a market capitalization of $453.3M, beta of 0.88 relative to the broader market, 52-week range of 13.46-31.04. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does FLGT belong to?
- Fulgent Genetics, Inc. operates in the Healthcare sector, in the Medical - Diagnostics & Research industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare FLGT's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the FLGT data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).